3,4-Methylenedioxy-''N''-methylphentermine

3,4-Methylenedioxy-N-methylphentermine
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N,2-dimethylpropan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C12H17NO2
Molar mass 207.269 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

3,4-Methylenedioxy-N-methylphentermine (MDMP), or 3,4-methylenedioxy-α,α,N-trimethylphenethylamine, is a lesser-known psychedelic drug. MDMP was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 110 mg, and the duration is listed as approximately 6 hours. MDMP produces few to no effects, and is slightly similar to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMP.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also

References

  1. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.